Fox Run Management’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-6,536
| Closed | -$310K | – | 876 |
|
|
2025
Q3 | $310K | Buy |
+6,536
| New | +$316K | 0.05% | 667 |
|
|
2025
Q2 | – | Sell |
-15,848
| Closed | -$642K | – | 830 |
|
|
2025
Q1 | $642K | Buy |
+15,848
| New | +$672K | 0.1% | 384 |
|
|
2024
Q2 | – | Sell |
-12,823
| Closed | -$324K | – | 754 |
|
|
2024
Q1 | $324K | Buy |
+12,823
| New | +$308K | 0.07% | 515 |
|
|
2023
Q2 | – | Sell |
-7,924
| Closed | -$303K | – | 659 |
|
|
2023
Q1 | $303K | Buy |
+7,924
| New | +$353K | 0.1% | 399 |
|
